X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html
http://www.prnewswire.com/news-releases/us-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease-642355963.html
http://www.fiercepharma.com/regulatory/fda-approval-partnership-takes-a-big-leap-expanding-chagas-drug-access
https://www.forbes.com/sites/judystone/2017/03/11/rare-disease-patients-need-more-than-miracles-and-trumpcare/
http://www.reuters.com/article/us-kalobios-pricing-idUSKCN0X81HO
http://www.forbes.com/sites/brucelee/2015/12/16/why-martin-shkrelis-price-hike-may-hurt-everyone-including-you-and-the-pharmaceutical-industry/?ss=pharma-healthcare
http://www.thestate.com/news/business/national-business/article49385725.html?
http://www.prnewswire.com/news-releases/kalobios-announces-agreement-to-acquire-benznidazole-program-for-the-treatment-of-chagas-disease-300187977.html
http://www.news-medical.net/news/20150901/Benznidazole-has-significant-antiparasitic-activity-but-does-not-reduce-progression-of-Chagas-cardiomyopathy.aspx?utm_source=twitterfeed&utm_medium=twitter&utm_campaign=DTN+Pharma+News:
Market Place
Share 
